News from anthera pharmaceuticals A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 18, 2012, 16:22 ET

Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), today announced that it intends to offer and sell shares of its common stock in an...

Jul 16, 2012, 13:26 ET

Anthera Pharmaceuticals Provides Additional Data from the Recently Completed PEARL-SC Study of Blisibimod in the Proposed Phase 3 Population

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation...

Jul 09, 2012, 17:02 ET

Anthera Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with...

Jun 27, 2012, 17:40 ET

Anthera Updates Phase 3 Plans Following Results from the Phase 2b PEARL-SC Dose Ranging Study of Blisibimod

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with...

May 03, 2012, 17:00 ET

Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update

 Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and business highlights for the quarter ended March 31, 2012....

Apr 27, 2012, 12:00 ET

Anthera Announces First Quarter 2012 Financial Report and Conference Call

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with...

Apr 25, 2012, 14:29 ET

Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation...

Apr 17, 2012, 15:00 ET

Anthera Pharmaceuticals to Present at the BioCentury Future Leaders Conference

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with...

Mar 15, 2012, 17:00 ET

Anthera Provides Corporate Update on Recent Activities

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation...

Mar 09, 2012, 17:00 ET

Anthera Halts VISTA-16 Clinical Study Due to Lack of Efficacy Following Recommendation by the Independent Data Safety Monitoring Board

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation...

Mar 05, 2012, 17:00 ET

Dr. Bogdan Dziurzynski Joins Anthera Pharmaceuticals Board of Directors

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases including cardiovascular and...

Mar 05, 2012, 08:00 ET

Anthera Pharmaceuticals Completes Interim Analysis of PEARL-SC Clinical Trial with Blisibimod

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases including cardiovascular and...

Feb 23, 2012, 17:00 ET

Anthera Pharmaceuticals to Present at the Citi Global Health Care Conference

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation...

Feb 21, 2012, 08:00 ET

Anthera Pharmaceuticals Reports 2011 Fourth Quarter Financial Results and Provides Clinical Progress Update

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and business highlights for the quarter ended December 31, 2011....

Feb 09, 2012, 17:00 ET

Anthera Announces Fourth Quarter 2011 Financial Report and Conference Call

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with...

Dec 14, 2011, 17:00 ET

Anthera Announces Completion of Safety Review by DSMB for VISTA-16

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation...

Dec 05, 2011, 17:00 ET

Anthera Pharmaceuticals Promotes Dr. Debra Odink to Chief Technology Officer

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing therapeutics to treat serious diseases associated with...

Dec 01, 2011, 08:00 ET

Anthera Pharmaceuticals Completes Interim B-Cell Analysis of PEARL-SC Study

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation,...

Nov 01, 2011, 16:15 ET

Anthera Pharmaceuticals Reports 2011 Third Quarter Financial Results and Operational Update

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), today announced financial results and business highlights for the quarter ended September 30, 2011....

Oct 25, 2011, 16:30 ET

Anthera Announces Last Patient Enrolled in PEARL-SC Study

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation,...